GB2007654A - 6,7-Dialkoxy-4-(4-substituted piperidino)quinazolines - Google Patents
6,7-Dialkoxy-4-(4-substituted piperidino)quinazolinesInfo
- Publication number
- GB2007654A GB2007654A GB7842677A GB7842677A GB2007654A GB 2007654 A GB2007654 A GB 2007654A GB 7842677 A GB7842677 A GB 7842677A GB 7842677 A GB7842677 A GB 7842677A GB 2007654 A GB2007654 A GB 2007654A
- Authority
- GB
- United Kingdom
- Prior art keywords
- group
- alkyl
- quinazolines
- dialkoxy
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003246 quinazolines Chemical class 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 239000000496 cardiotonic agent Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000010561 standard procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Quinazoline cardiac stimulants of the formula: <IMAGE> wherein R is a C1-6 alkyl group; and Y represents a group of the formula: -(CHR<1>)m-Z wherein R<1> is a hydrogen atom or a C1-6 alkyl group, and m is 1 or 2, with the proviso that when m is 2, each R<1> may be the same or different; and Z is a group selected from: -OCONR<4>R<5> -N(R<2>)COR<3> -N(R<2>)SO2R<3> and -N(R<2>)CONR<4>R<5> wherein R<2> is hydrogen or C1-6 alkyl, R<3> is C1-6 alkyl, benzyl, or phenyl, and R<4> and R<5> are each independently hydrogen or a group as defined for R<3> above; the pharmaceutically acceptable acid addition salts thereof; and pharmaceutical compositions containing them; are prepared by standard methods.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7842677A GB2007654B (en) | 1977-11-03 | 1978-10-31 | Therapeutic agents |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4566977 | 1977-11-03 | ||
| GB7842677A GB2007654B (en) | 1977-11-03 | 1978-10-31 | Therapeutic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB2007654A true GB2007654A (en) | 1979-05-23 |
| GB2007654B GB2007654B (en) | 1982-06-16 |
Family
ID=26265634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB7842677A Expired GB2007654B (en) | 1977-11-03 | 1978-10-31 | Therapeutic agents |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2007654B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0017411A1 (en) * | 1979-03-28 | 1980-10-15 | Pfizer Limited | Phthalazine cardiac stimulants, processes for preparing them, and pharmaceutical compositions containing them |
| US6518423B1 (en) | 1996-08-09 | 2003-02-11 | Eisai Co., Ltd. | Benzopiperidine derivatives |
-
1978
- 1978-10-31 GB GB7842677A patent/GB2007654B/en not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0017411A1 (en) * | 1979-03-28 | 1980-10-15 | Pfizer Limited | Phthalazine cardiac stimulants, processes for preparing them, and pharmaceutical compositions containing them |
| US6518423B1 (en) | 1996-08-09 | 2003-02-11 | Eisai Co., Ltd. | Benzopiperidine derivatives |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2007654B (en) | 1982-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK623586D0 (en) | PIPERIDE INGREDIENTS OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS | |
| DK225081A (en) | AMINOPROPIOPHENON DERIVATIVES AND THEIR ACID ADDITIONAL SALT PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS GUNGICIDES | |
| GB2003731A (en) | The use of imidazole derivatives as fungicides | |
| GB2007654A (en) | 6,7-Dialkoxy-4-(4-substituted piperidino)quinazolines | |
| DK379281A (en) | AZOLYLALKYL DERIVATIVES PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES | |
| SE7703000L (en) | PROCEDURE FOR THE PREPARATION OF CARBOSTYRIL DERIVATIVES | |
| IE42617L (en) | Novel diaryloxytriazolyl-o,n-acetals and their use as¹fungicides | |
| IL48453A (en) | Substituted 6-oxa-1-azatricyclo-(6.2.2.0 )dodecan-5-ones and 1,4-ethano-5-oxo octa (or decahydro)quinoline,their preparation and pharmaceutical compositions containing them | |
| ATE50248T1 (en) | AN IMIDAZOLIDINETRIONE DERIVATIVE OR A PHARMACEUTICAL COMPOSITION CONTAINING ITS PHARMACEUTICALLY ACCEPTABLE SALTS. | |
| SE8302345L (en) | PLEUROMUTILIN DERIVATIVES, THE PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS A MEDICINAL PRODUCT | |
| ES482138A1 (en) | Phenylpiperidine derivatives, processes for their preparation and pharmaceutical compositions containing them. | |
| IE44373L (en) | Pyridthione derivatives | |
| GB2008104A (en) | Phthalazines | |
| JPS5618967A (en) | Azolyllalkenol* its manufacture and its use as bactericide | |
| ATE29877T1 (en) | MEANS OF LOWERING HEART RATE. | |
| NO864045L (en) | NEW ALFA, ALFA-DIARYL-4-ARYL-4-HYDROXY-1-PIPERIDINBUTANAMIDE, N-OXYDER. | |
| GB1420758A (en) | Anti-ulcer compositions | |
| JPS5430167A (en) | 4-aminomethyl-2-phenyloxazoles and their pharmaceutically acceptable acid salts | |
| ES444384A1 (en) | Biguanides and therapeutic compositions and uses of the same | |
| DE69016378D1 (en) | Substituted benzothiazolinones, their preparation and pharmaceutical compositions containing them. | |
| SE7905025L (en) | TEREFTALIC ACID MONOAMIDE DERIVATIVE, PROCEDURE FOR THE PREPARATION AND ANTIALLERGIC | |
| JPS5430162A (en) | 2-aminomethyl-5-phenyloxazoles and their pharmaceutically acceptable acid salts | |
| JPS5436252A (en) | Novel propano-anthracene derivatives and their preparation | |
| JPS5430126A (en) | Benzyl alcohol derivatives and their preparation | |
| ES442931A3 (en) | Procedure for the preparation of 2H, 3h-benzymidazo- (1,2-b) -oxazole. (Machine-translation by Google Translate, not legally binding) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |